These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
461 related articles for article (PubMed ID: 27122510)
1. Trends in the incidence of atypical femoral fractures and bisphosphonate therapy. Clout A; Narayanasamy N; Harris I J Orthop Surg (Hong Kong); 2016 Apr; 24(1):36-40. PubMed ID: 27122510 [TBL] [Abstract][Full Text] [Related]
2. Critical differences between subtrochanteric and diaphyseal atypical femoral fractures: analyses of 51 cases at a single institution in Korean population. Cho YJ; Kang KC; Chun YS; Rhyu KH; Kim SJ; Jang TS Arch Osteoporos; 2018 May; 13(1):53. PubMed ID: 29725835 [TBL] [Abstract][Full Text] [Related]
3. Bisphosphonate Use and Risk of Atypical Femoral Fractures: A Danish Case-Cohort Study With Blinded Radiographic Review. Bauer DC; Black DM; Dell R; Fan B; Smith CD; Ernst MT; Jurik AG; Frøkjær JB; Boesen M; Vittinghoff E; Abrahamsen B J Clin Endocrinol Metab; 2024 Oct; 109(11):e2141-e2150. PubMed ID: 38198798 [TBL] [Abstract][Full Text] [Related]
4. Incidence and medical management of bisphosphonate-associated atypical femoral fractures in a major trauma centre: a retrospective observational study. Eisenstein N; Kasavkar G; Bhavsar D; Khan FS; Paskins Z BMC Musculoskelet Disord; 2017 Jan; 18(1):29. PubMed ID: 28114975 [TBL] [Abstract][Full Text] [Related]
5. Outcomes between older adults with atypical and typical femoral fractures are comparable. Khow KS; Paterson F; Shibu P; Yu SC; Chehade MJ; Visvanathan R Injury; 2017 Feb; 48(2):394-398. PubMed ID: 27839798 [TBL] [Abstract][Full Text] [Related]
6. Biological activity is not suppressed in mid-shaft stress fracture of the bowed femoral shaft unlike in "typical" atypical subtrochanteric femoral fracture: A proposed theory of atypical femoral fracture subtypes. Oh Y; Yamamoto K; Hashimoto J; Fujita K; Yoshii T; Fukushima K; Kurosa Y; Wakabayashi Y; Kitagawa M; Okawa A Bone; 2020 Aug; 137():115453. PubMed ID: 32470545 [TBL] [Abstract][Full Text] [Related]
7. Incidence Rate of Atypical Femoral Fracture after Bisphosphonates Treatment in Korea. Lee YK; Ahn S; Kim KM; Suh CS; Koo KH J Korean Med Sci; 2018 Jan; 33(5):e38. PubMed ID: 29349947 [TBL] [Abstract][Full Text] [Related]
8. Study of Atypical Femoral Fracture Cases Coupled in a Multicenter Study. Zenke Y; Ikeda S; Fukuda F; Tanaka M; Tanaka H; Hirano F; Sakai A J UOEH; 2016 Sep; 38(3):207-14. PubMed ID: 27627968 [TBL] [Abstract][Full Text] [Related]
9. T-Score Discordance of Bone Mineral Density in Patients with Atypical Femoral Fracture. Lee KJ; Min BW; Song KS; Bae KC; Cho CH; Lee SW J Bone Joint Surg Am; 2017 Oct; 99(19):1683-1688. PubMed ID: 28976433 [TBL] [Abstract][Full Text] [Related]
10. Frequency and associated factor of atypical periprosthetic femoral fracture after hip arthroplasty. Lee YK; Park CH; Kim KC; Hong SH; Ha YC; Koo KH Injury; 2018 Dec; 49(12):2264-2268. PubMed ID: 30245278 [TBL] [Abstract][Full Text] [Related]
11. Adherence to oral bisphosphonates and the risk of subtrochanteric and femoral shaft fractures among female medicare beneficiaries. Wang Z; Ward MM; Chan L; Bhattacharyya T Osteoporos Int; 2014 Aug; 25(8):2109-16. PubMed ID: 24846316 [TBL] [Abstract][Full Text] [Related]
12. Incidence, risk factors, and fracture healing of atypical femoral fractures: a multicenter case-control study. Lim SJ; Yeo I; Yoon PW; Yoo JJ; Rhyu KH; Han SB; Lee WS; Song JH; Min BW; Park YS Osteoporos Int; 2018 Nov; 29(11):2427-2435. PubMed ID: 30039251 [TBL] [Abstract][Full Text] [Related]
13. Atypical Femoral Fractures Can Happen Even With Short Duration Bisphosphonate Treatment. Kohli R; Siva C Conn Med; 2015 Aug; 79(7):419-22. PubMed ID: 26411180 [TBL] [Abstract][Full Text] [Related]
14. High bisphosphonate treatment rates and the prevalence of atypical femoral fractures in patients with systematic lupus erythematosus: a single-center retrospective study performed in Japan. Sato H; Kondo N; Wakamatsu A; Kobayashi D; Nakatsue T; Wada Y; Kuroda T; Suzuki Y; Nakano M; Endo N; Narita I Rheumatol Int; 2019 Oct; 39(10):1803-1810. PubMed ID: 31385078 [TBL] [Abstract][Full Text] [Related]
15. Association of atypical femoral fractures with bisphosphonate use by patients with varus hip geometry. Hagen JE; Miller AN; Ott SM; Gardner M; Morshed S; Jeray K; Alton TB; Ren D; Abblitt WP; Krieg JC J Bone Joint Surg Am; 2014 Nov; 96(22):1905-9. PubMed ID: 25410509 [TBL] [Abstract][Full Text] [Related]
16. Atypical Periprosthetic Femoral Fracture Might be Considered a Distinct Subtype of Atypical Femoral Fracture: A Retrospective Study. Huang K; Zeng Y; Zhang Q; Tan J; Li H; Yang J; Xie H; Shen B Orthop Surg; 2024 Oct; 16(10):2454-2463. PubMed ID: 39072929 [TBL] [Abstract][Full Text] [Related]
17. Bisphosphonates and risk of subtrochanteric, femoral shaft, and atypical femur fracture: a systematic review and meta-analysis. Gedmintas L; Solomon DH; Kim SC J Bone Miner Res; 2013 Aug; 28(8):1729-37. PubMed ID: 23408697 [TBL] [Abstract][Full Text] [Related]
18. Retrospective review of patients with atypical bisphosphonate related proximal femoral fractures. Phillips HK; Harrison SJ; Akrawi H; Sidhom SA Injury; 2017 Jun; 48(6):1159-1164. PubMed ID: 28410753 [TBL] [Abstract][Full Text] [Related]
19. Risk factors for development of atypical femoral fractures in patients on long-term oral bisphosphonate therapy. Franceschetti P; Bondanelli M; Caruso G; Ambrosio MR; Lorusso V; Zatelli MC; Massari L; Degli Uberti EC Bone; 2013 Oct; 56(2):426-31. PubMed ID: 23871850 [TBL] [Abstract][Full Text] [Related]